These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16874903)

  • 1. Clopidogrel for the prevention of atherothrombotic events.
    Kongsaengdao S; Arayawichanont A
    N Engl J Med; 2006 Jul; 355(4):419-20; author reply 420-1. PubMed ID: 16874903
    [No Abstract]   [Full Text] [Related]  

  • 2. Clopidogrel for the prevention of atherothrombotic events.
    Kamalesh M
    N Engl J Med; 2006 Jul; 355(4):420; author reply 420-1. PubMed ID: 16874904
    [No Abstract]   [Full Text] [Related]  

  • 3. Clopidogrel for the prevention of atherothrombotic events.
    Rozenman Y
    N Engl J Med; 2006 Jul; 355(4):419; author reply 420-1. PubMed ID: 16871688
    [No Abstract]   [Full Text] [Related]  

  • 4. Clopidogrel for the prevention of atherothrombotic events.
    Almanaseer Y; Desai DM
    N Engl J Med; 2006 Jul; 355(4):420; author reply 420-1. PubMed ID: 16871689
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin Plus Clopidogrel vs Aspirin Alone for Preventing Cardiovascular Events Among Patients at High Risk for Cardiovascular Events.
    Donadini MP; Bellesini M; Squizzato A
    JAMA; 2018 Aug; 320(6):593-594. PubMed ID: 30054611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.
    Bhatt DL; Fox KA; Hacke W; Berger PB; Black HR; Boden WE; Cacoub P; Cohen EA; Creager MA; Easton JD; Flather MD; Haffner SM; Hamm CW; Hankey GJ; Johnston SC; Mak KH; Mas JL; Montalescot G; Pearson TA; Steg PG; Steinhubl SR; Weber MA; Brennan DM; Fabry-Ribaudo L; Booth J; Topol EJ;
    N Engl J Med; 2006 Apr; 354(16):1706-17. PubMed ID: 16531616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clopidogrel plus aspirin in atrial fibrillation.
    Goldstein LB
    N Engl J Med; 2009 Sep; 361(13):1313; author reply 1314-5. PubMed ID: 19780217
    [No Abstract]   [Full Text] [Related]  

  • 8. Summaries for patients. Is it cost-effective to treat high-risk cardiac patients with clopidogrel plus aspirin as opposed to aspirin alone?
    Ann Intern Med; 2005 Feb; 142(4):I53. PubMed ID: 15710954
    [No Abstract]   [Full Text] [Related]  

  • 9. Clopidogrel plus aspirin in atrial fibrillation.
    Richard T; Butaffuoco F; Vanhaeverbeek M
    N Engl J Med; 2009 Sep; 361(13):1313; author reply 1314-5. PubMed ID: 19780216
    [No Abstract]   [Full Text] [Related]  

  • 10. Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials.
    Helton TJ; Bavry AA; Kumbhani DJ; Duggal S; Roukoz H; Bhatt DL
    Am J Cardiovasc Drugs; 2007; 7(4):289-97. PubMed ID: 17696569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of clopidogrel plus aspirin for secondary prevention of cardiovascular events in Canada for patients with established cardiovascular disease: Results from the CHARISMA trial.
    Chen J; Shi C; Mahoney EM; Dunn ES; Rinfret S; Caro JJ; O'Brien J; El-Hadi W; Bhatt DL; Topol EJ; Cohen DJ
    Can J Cardiol; 2011; 27(2):222-31. PubMed ID: 21459271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and tolerability of antiplatelet therapies for the secondary prevention of atherothrombotic disease.
    Spinler SA
    Pharmacotherapy; 2009 Jul; 29(7):812-21. PubMed ID: 19558255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clopidogrel versus aspirin and esomeprazole to prevent recurrent bleeding.
    Wolk MJ; Jacobs AK
    N Engl J Med; 2005 Apr; 352(16):1716-8; author reply 1716-8. PubMed ID: 15843675
    [No Abstract]   [Full Text] [Related]  

  • 14. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
    Bhatt DL; Topol EJ;
    Am Heart J; 2004 Aug; 148(2):263-8. PubMed ID: 15308995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clopidogrel for the prevention of atherothrombotic events.
    Rabinstein AA
    N Engl J Med; 2006 Jul; 355(4):418-9; author reply 420-1. PubMed ID: 16870924
    [No Abstract]   [Full Text] [Related]  

  • 16. Aspirin or clopidogrel for secondary prevention of cardiovascular events: is there a winner?
    Gaspoz JM; de Moerloose P
    Am J Med; 2004 Jun; 116(12):850-2. PubMed ID: 15178502
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thienopyridines in the treatment and prevention of cardiovascular diseases. III. therapeutic application of clopidogrel as monotherapy (without acetylsalicylic acid)].
    Preobrazhenskiĭ DV; Sidorenko BA; Batyraliev TA; Vural A; Islek M; Avsar O; Fettser DV
    Kardiologiia; 2009; 49(12):63-7. PubMed ID: 20038285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clopidogrel added to aspirin adds no benefit but bleeding risk in patients with recent lacunar stroke.
    Diener HC; Weber R
    Stroke; 2013 Mar; 44(3):861-3. PubMed ID: 23339960
    [No Abstract]   [Full Text] [Related]  

  • 19. [ASS or clopidogrel plus esomeprazole after bleeding from an ulcer].
    Nitschmann S; Mössner J
    Internist (Berl); 2005 Dec; 46(12):1405-8. PubMed ID: 16220275
    [No Abstract]   [Full Text] [Related]  

  • 20. Benefit of aspirin not surpassed by combining clopidogrel with aspirin in dual anti-platelet prevention of atherothrombotic events in high-risk patients : drug trends in cardiology.
    Cardiovasc J S Afr; 2006; 17(2):96, 98; discussion 98. PubMed ID: 16733607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.